Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination
- 1 May 2012
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 102 (5), 893-898
- https://doi.org/10.2105/ajph.2011.300576
Abstract
We sought to investigate roles that Merck & Co Inc played in state human papillomavirus (HPV) immunization policymaking, to elicit key stakeholders' perceptions of the appropriateness of these activities, and to explore implications for relationships between health policymakers and industry. We used a series of state case studies combining data from key informant interviews with analysis of media reports and archival materials. We interviewed 73 key informants in 6 states that were actively engaged in HPV vaccine policy deliberations. Merck promoted school-entry mandate legislation by serving as an information resource, lobbying legislators, drafting legislation, mobilizing female legislators and physician organizations, conducting consumer marketing campaigns, and filling gaps in access to the vaccine. Legislators relied heavily on Merck for scientific information. Most stakeholders found lobbying by vaccine manufacturers acceptable in principle, but perceived that Merck had acted too aggressively and nontransparently in this case. Although policymakers acknowledge the utility of manufacturers' involvement in vaccination policymaking, industry lobbying that is overly aggressive, not fully transparent, or not divorced from financial contributions to lawmakers risks undermining the prospects for legislation to foster uptake of new vaccines.Keywords
This publication has 9 references indexed in Scilit:
- Mandatory HPV Vaccination and Political DebatePublished by American Medical Association (AMA) ,2011
- Controversy Undermines Support For State Mandates On The Human Papillomavirus VaccineHealth Affairs, 2010
- HPV Vaccination's Second Act: Promotion, Competition, and CompulsionAmerican Journal of Public Health, 2010
- HPV Vaccination Mandates — Lawmaking amid Political and Scientific ControversyNew England Journal of Medicine, 2010
- Marketing HPV VaccineJAMA, 2009
- Lessons from the Failure of Human Papillomavirus Vaccine State RequirementsClinical Pharmacology & Therapeutics, 2007
- Public Health, Public Trust and LobbyingAmerican Journal of Bioethics, 2007
- Mandatory HPV VaccinationPublished by American Medical Association (AMA) ,2007
- Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR. Recommendations and Reports, 2007